- Home
- ZUMZ vs OLMA Comparison
ZUMZ vs OLMA Comparison
Compare ZUMZ & OLMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZUMZ
- OLMA
- Stock Information
- Founded
- ZUMZ 1978
- OLMA 2006
- Country
- ZUMZ United States
- OLMA United States
- Employees
- ZUMZ N/A
- OLMA N/A
- Industry
- ZUMZ Clothing/Shoe/Accessory Stores
- OLMA Biotechnology: Pharmaceutical Preparations
- Sector
- ZUMZ Consumer Discretionary
- OLMA Health Care
- Exchange
- ZUMZ Nasdaq
- OLMA Nasdaq
- Market Cap
- ZUMZ 247.5M
- OLMA 289.0M
- IPO Year
- ZUMZ 2005
- OLMA 2020
- Fundamental
- Price
- ZUMZ $12.49
- OLMA $5.28
- Analyst Decision
- ZUMZ Hold
- OLMA Strong Buy
- Analyst Count
- ZUMZ 2
- OLMA 4
- Target Price
- ZUMZ $22.00
- OLMA $24.50
- AVG Volume (30 Days)
- ZUMZ 220.1K
- OLMA 688.0K
- Earning Date
- ZUMZ 06-05-2025
- OLMA 05-13-2025
- Dividend Yield
- ZUMZ N/A
- OLMA N/A
- EPS Growth
- ZUMZ N/A
- OLMA N/A
- EPS
- ZUMZ N/A
- OLMA N/A
- Revenue
- ZUMZ $889,202,000.00
- OLMA N/A
- Revenue This Year
- ZUMZ $3.19
- OLMA N/A
- Revenue Next Year
- ZUMZ $1.71
- OLMA N/A
- P/E Ratio
- ZUMZ N/A
- OLMA N/A
- Revenue Growth
- ZUMZ 1.57
- OLMA N/A
- 52 Week Low
- ZUMZ $11.31
- OLMA $2.86
- 52 Week High
- ZUMZ $31.37
- OLMA $16.62
- Technical
- Relative Strength Index (RSI)
- ZUMZ 47.58
- OLMA 60.00
- Support Level
- ZUMZ $11.66
- OLMA $4.80
- Resistance Level
- ZUMZ $13.31
- OLMA $5.61
- Average True Range (ATR)
- ZUMZ 0.50
- OLMA 0.38
- MACD
- ZUMZ 0.03
- OLMA 0.02
- Stochastic Oscillator
- ZUMZ 40.89
- OLMA 78.71
About ZUMZ Zumiez Inc.
Zumiez Inc is a United-States-based specialty retailer engaged in the sale of apparel, footwear, accessories, and hard goods. The company provides merchandise with cultural elements coming from fashion, music, art from action sports, streetwear, and other lifestyles. The company operates under the brands Zumiez, Fast Times, and Blue Tomato, and through both physical stores and websites. The majority of the company's stores are located in the U.S., with the rest in Canada, Australia, and Europe. The U.S. market contributes to the majority of the company's revenue.
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.